The Patent Finder

Translational Drug Development, LLC

14 patents currently held · Updated Nov 16, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

4
Ending by 2030
Jun 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 27, 2027
    The maintenance fee for Heterocyclic compounds as kinase inhibitors (US 10,392,402) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
  • 1 fee due Mar 8, 2027
    The maintenance fee for 4-(benzimidazol-2-ylamino)benzamide derivatives and salts or solvates thereof (US 9,125,901) comes due Mar 8, 2027. Unpaid by Sep 8, 2027, it lapses early.
  • 1 fee due Apr 10, 2027
    The maintenance fee for Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase (US 11,780,816) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 1 fee due Jun 29, 2027
    The maintenance fee for Benzamide derivatives (US 9,221,773) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
  • 1 fee due Sep 17, 2027
    The maintenance fee for 4-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof (US 10,590,088) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
  • 1 fee due Oct 28, 2027
    The maintenance fee for Heterocyclic compounds as kinase inhibitors (US 10,633,393) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,464,059Benzamide derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,590,0884-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,125,9014-(benzimidazol-2-ylamino)benzamide derivatives and salts or solvates thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,221,773Benzamide derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,987,468Compounds, Pharmaceutical Compositions and Methods of Use of Hydroxamic Acid Derivatives
In force
 · High confidence
In forceHigh confidence
US 10,392,402Heterocyclic compounds as kinase inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,633,393Heterocyclic compounds as kinase inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,881,733Benzamide and active compound compositions and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,738,007Amide compounds as kinase inhibitors, compositions and methods of treatment
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,780,080Benzamide and active compound compositions and methods of use
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
Also on record, not counted in the 14: 1 patent in force now held by others · 5 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited